September 24, 2020

The Niche

Knoepfler lab stem cell blog

Goldwater Institute Right To Try

2 min read

Should patients have the Right To Try experimental therapies that could be unsafe and ineffective? What if those patients have a terminal illness and no reasonable prospects of being helpful to conventional medicine? Doesn’t it make perfect sense to let them try a risky approach if they want to do so? On the other hand, could some businesses capitalize on Right-To-Try to try to make a lot of money off of vulnerable patients? Right-To-Try sparks many tough questions like these and there is often …Read More